128 related articles for article (PubMed ID: 22308730)
1. [Dependence of IgG titers specific to various hepatitis C virus proteins on features of chronic infection course].
Poponin DM; Gorovits ÉS; Bondarenko AL
Zh Mikrobiol Epidemiol Immunobiol; 2011; (6):57-61. PubMed ID: 22308730
[TBL] [Abstract][Full Text] [Related]
2. [Spectrum of antibodies to HCV antigens in patients with different clinical patterns of chronic HCV infection].
Kruglov IV; Znoĭko OO; Ogienko OL; Ianina MV; Finogenova MP; Alekseenkova TI; Braginskiĭ DM; Kuzin SN; Sukhanova LL; Grinev AA; Selivanov NA; Doroshenko NV; Shibnev VA; Semiletov IuA
Vopr Virusol; 2002; 47(2):11-6. PubMed ID: 12046459
[TBL] [Abstract][Full Text] [Related]
3. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
[TBL] [Abstract][Full Text] [Related]
4. Generation and characterization of chimeric antibodies against NS3, NS4, NS5, and core antigens of hepatitis C virus.
Tu B; Ziemann RN; Tieman BC; Hawksworth DJ; Tyner J; Scheffel J; Pinkus MS; Brophy SE; Werneke JM; Gutierrez R; White M
Clin Vaccine Immunol; 2010 Jun; 17(6):1040-7. PubMed ID: 20427624
[TBL] [Abstract][Full Text] [Related]
5. Monitoring antibody titers to recombinant Core-NS3 fusion polypeptide is useful for evaluating hepatitis C virus infection and responses to interferon-alpha therapy.
Park YM; Byun BH; Choi JY; Bae SH; Kim BS; So HS; Ryu WS
J Korean Med Sci; 1999 Apr; 14(2):165-70. PubMed ID: 10331562
[TBL] [Abstract][Full Text] [Related]
6. Low-level hepatitis C viremia and humoral immune response to NS4 in chronic hepatitis B virus-hepatitis C virus coinfection.
Chu CM; Sheen IS; Liaw YF
Scand J Gastroenterol; 2004 Aug; 39(8):778-82. PubMed ID: 15513365
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the antibody reactivity to synthetic peptides from different parts of the hepatitis C virus genome.
Pujol FH; Khudyakov YE; Devesa M; León G; Blitz-Dorfman L; Monsalve F; Lambert SB; Kalinina TY; Liprandi F; Fields HA
Viral Immunol; 1996; 9(2):89-96. PubMed ID: 8822625
[TBL] [Abstract][Full Text] [Related]
8. Changes in hepatitis C virus (HCV) antibody status in patients with chronic hepatitis C after eradication of HCV infection by interferon therapy.
Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kuzuya T; Honda T; Hayashi K; Nakano I; Katano Y; Goto H
Clin Infect Dis; 2005 Mar; 40(6):e49-54. PubMed ID: 15736006
[TBL] [Abstract][Full Text] [Related]
9. [Antibodies to different virus antigens in patients with chronic hepatitis C].
Krasavtsev EL; Zhavoronok SV; Mitsura VM; Demchilo AP
Zh Mikrobiol Epidemiol Immunobiol; 2006; (2):57-61. PubMed ID: 16758901
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic significance of antibody detection to various hepatitis C virus antigens in patients with acute and chronic HCV-infection].
Iushchuk ND; Ogienko OL; Kruglov IV; Znoĭko OO; Braginskiĭ DM; Semiletov IuA; Finogenova MP; Alekseenkova TI; Ianina MV; Shibnev VA; Doroshenko NV
Ter Arkh; 2002; 74(4):18-22. PubMed ID: 12043232
[TBL] [Abstract][Full Text] [Related]
11. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response.
Chu CM; Sheen IS; Liaw YF
Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075
[TBL] [Abstract][Full Text] [Related]
12. IgE antibodies to hepatitis C virus core and nonstructural antigens in chronic hepatitis C patients before and after antiviral treatment.
Silva JPCG; Jesus LS; Isabel Schinoni M; Oliveira IS; Atta MLBS; Atta AM
Int Immunopharmacol; 2021 Apr; 93():107405. PubMed ID: 33529909
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus (HCV)-related cryoglobulinemia: cryoglobulin type and anti-HCV profile.
Minopetrou M; Hadziyannis E; Deutsch M; Tampaki M; Georgiadou A; Dimopoulou E; Vassilopoulos D; Koskinas J
Clin Vaccine Immunol; 2013 May; 20(5):698-703. PubMed ID: 23467778
[TBL] [Abstract][Full Text] [Related]
14. A novel antigen detection immunoassay for field diagnosis of hepatitis C virus infection.
Attallah AM; Ismail H; Tabll AA; Shiha GE; El-Dosoky I
J Immunoassay Immunochem; 2003; 24(4):395-407. PubMed ID: 14677657
[TBL] [Abstract][Full Text] [Related]
15. The relationship between virological characteristics of hepatitis C virus (HCV) and reactivity to the regional specific proteins of HCV.
Yoon SK; Park YM; Byun BH; Bae SH; Yang JM; Ahn BM; Lee YS; Lee CD; Sun HS; Kim BS
Korean J Intern Med; 2000 Jul; 15(2):109-16. PubMed ID: 10992722
[TBL] [Abstract][Full Text] [Related]
16. IgG1 and IgG4 antibodies against Core and NS3 antigens of hepatitis C virus.
Santos VCD; Schinoni MI; Oliveira IS; Atta MLS; Atta AM
Rev Soc Bras Med Trop; 2019 Mar; 52():e20180491. PubMed ID: 30843970
[TBL] [Abstract][Full Text] [Related]
17. Virus-specific antibody titres in different phases of hepatitis C virus infection.
Nikolaeva LI; Blokhina NP; Tsurikova NN; Voronkova NV; Miminoshvili MI; Braginsky DM; Yastrebova ON; Booynitskaya OB; Isaeva OV; Michailov MI; Archakov AI
J Viral Hepat; 2002 Nov; 9(6):429-37. PubMed ID: 12431205
[TBL] [Abstract][Full Text] [Related]
18. Identification of antigenic sites on three hepatitis C virus proteins using phage-displayed peptide libraries.
Pereboeva LA; Pereboev AV; Morris GE
J Med Virol; 1998 Oct; 56(2):105-11. PubMed ID: 9746064
[TBL] [Abstract][Full Text] [Related]
19. The 1F7 idiotype is selectively expressed on CD5+ B cells and elevated in chronic hepatitis C virus infection.
Davtyan TK; Hovsepyan MP; Mkhitaryan LM; Hakobyan GS; Brazil A; Barrett L; Hirsch G; Peltekian KM; Grant MD
Immunol Cell Biol; 2009; 87(6):457-63. PubMed ID: 19333248
[TBL] [Abstract][Full Text] [Related]
20. [Spontaneous HCV clearance: an association with gender, age, viral genotypes, infection transmission routes, and markers of HBV and HIV].
Fedorchenko SV; Martynovich TL; Liashok OV; Kariuk ZhA; Ianchenko VI
Ter Arkh; 2010; 82(3):52-6. PubMed ID: 20564924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
